When Progress Fails to Materialize: When new cancer drugs become available and who receives them - Couverture souple
Résultats de recherche pour When Progress Fails to Materialize: When new cancer...
Image d'archives
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Edité par
Bremen University Press, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Couverture souple
Vendeur : California Books, Miami, FL, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. N° de réf. du vendeur I-9783691733884
Acheter neuf
EUR 25,21
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
When Progress Fails to Materialize
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : New. N° de réf. du vendeur LU-9783691733884
Acheter neuf
EUR 26,13
Livraison gratuite
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
When Progress Fails to Materialize
impression à la demandeVendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9783691733884
Acheter neuf
EUR 25,66
Expédition à EUR 3,85
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Edité par
Bremen University Press, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Couverture souple
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. Print on Demand. N° de réf. du vendeur 408252279
Acheter neuf
EUR 31,10
Expédition à EUR 7,61
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 4 disponible(s)
Image d'archives
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Edité par
Bremen University Press, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Couverture souple
Vendeur : Books Puddle, New York, NY, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. Print on Demand. N° de réf. du vendeur 26404934824
Acheter neuf
EUR 36,24
Expédition à EUR 3,49
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 4 disponible(s)
Image d'archives
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Edité par
Bremen University Press, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Couverture souple
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18404934818
Acheter neuf
EUR 31,44
Expédition à EUR 9,95
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 4 disponible(s)
Image d'archives
When Progress Fails to Materialize
Edité par
Bremen University Press Sep 2025, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 116 pp. Englisch. N° de réf. du vendeur 9783691733884
Acheter neuf
EUR 20
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
When Progress Fails to Materialize (Paperback)
impression à la demandeVendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available. It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies. The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today. Bremen University Press has published over 5,000 specialist books in various languages since 2005. September 2025 This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9783691733884
Acheter neuf
EUR 29,52
Expédition à EUR 43,31
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
When Progress Fails to Materialize
Edité par
Bremen University Press Sep 2025, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available.It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies.The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today.Bremen University Press has published over 5,000 specialist books in various languages since 2005.September 2025Books on Demand GmbH, Überseering 33, 22297 Hamburg 116 pp. Englisch. N° de réf. du vendeur 9783691733884
Acheter neuf
EUR 20
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
When Progress Fails to Materialize : When new cancer drugs become available and who receives them
Edité par
Bremen University Press, 2025
ISBN 10 : 3691733883
ISBN 13 : 9783691733884
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available.It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies.The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today.Bremen University Press has published over 5,000 specialist books in various languages since 2005.September 2025. N° de réf. du vendeur 9783691733884
Acheter neuf
EUR 20
Expédition à EUR 60,88
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)